Plain-English translation of NCT05056701 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is looking for signs of chronic kidney disease in women who have had pre-eclampsia — a serious condition during pregnancy marked by high blood pressure and protein in the urine. The research team wants to understand how pre-eclampsia affects kidney health after pregnancy and to find ways to catch kidney problems early.
While pre-eclampsia usually gets better within a few months after delivery, doctors have noticed that women who experience it face a higher risk of developing kidney disease, high blood pressure, diabetes, and heart problems later in life. This study exists to better understand that connection and to develop early warning signs so doctors can help prevent serious kidney damage.
You likely qualify if…
You likely don't qualify if…
As a participant, you will likely undergo kidney function tests and provide blood or urine samples, and share information about your pregnancy history and current health. The exact schedule and number of visits will be explained to you when you enroll, but the goal is to monitor your kidney health and identify any early warning signs that might need treatment.
AI-generated summary from trial data · Jun 9, 2026 · Not medical advice
France
Centre Hospitalier le Mans
Enrollment target
~400 participants
Started
May 2022
Primary completion
May 2037
Age range
18 Years and older
Sex
Female only
Last updated on clinicaltrials.gov in September 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Christelle JADEAU
Centre Hospitalier le Mans
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.